Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: Rimegepant
- DRUG: Placebo
Sponsor
Pfizer